Sergio Pedraza‐Arévalo

Author

Also Known As

S Pedraza-Arevalo, S Pedraza-Arévalo, S. Pedraza-Arevalo, S. Pedraza-Arévalo, Sergio Pedraza-Arevalo, Sergio Pedraza-Arévalo, Sergio Pedraza‐Arevalo, Sergio Pedraza‐Arévalo

Publications

729

Citations

H-Index

Concepts

All Affiliations

University of Córdoba Instituto Maimónides de Investigación Biomédica de Córdoba Hospital Universitario Reina Sofía Centro de Investigación Biomédica en Red Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition

About

Sergio Pedraza‐Arévalo is an author at University of Córdoba specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	355
2	Cell Biology	4	4	174
3	Biochemistry	1	1	38
4	Diabetes	1	1	38
5	Endocrinology	1	1	38

Sergio Pedraza‐Arévalo

Publications

585

Citations

H-Index

Page 1

	Year	Citations
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Antonio J. Montero‐Hidalgo, EBioMedicine UrologyGenitourinary CancerMedicineRna SplicingPathology	2020	109
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3 Antonio C. Fuentes-Fayos, Mari C. Vázquez‐Borrego, Juan M. Jiménez‐Vacas, Brain High-grade GliomasAggressiveness ParametersGliomaCancer BiologySplicing Variant	2020	99
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá, Journal of Experimental & Clinical Cancer Research	2021	56
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution? Aura D. Herrera‐Martínez, Sergio Pedraza‐Arévalo, Fernando L‐López, The Journal of Clinical Endocrinology & Metabolism	2018	49
Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy Alejandro Ibáñez‐Costa, C. Pérez‐Sánchez, A. M. Patiño-Trives, Annals of the Rheumatic Diseases	2021	46
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker Daniel Hormaechea‐Agulla, Enrique Gómez‐Gómez, Alejandro Ibáñez‐Costa, Cancer Letters UrologyGrowth HormoneBiochemistryPathologyMetabolic Status	2016	38
An HNF1α truncation associated with maturity-onset diabetes of the young impairs pancreatic progenitor differentiation by antagonizing HNF1β function Ana-Maria Cujba, Mario Enrique Alvarèz Fallas, Sergio Pedraza‐Arévalo, Cell Reports Metabolic SyndromeHnf1α TruncationDevelopmental BiologyHnf1β FunctionDiabetes	2022	38
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer Sergio Pedraza‐Arévalo, Daniel Hormaechea‐Agulla, Enrique Gómez‐Gómez, The Prostate	2017	35
Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors Aura D. Herrera‐Martínez, Manuel D. Gahete, Sergio Pedraza‐Arévalo, Endocrine Functional ImplicationSurgical OncologyOncologyGastroenteropancreatic Neuroendocrine TumorsMedicine	2017	34
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors Sergio Pedraza‐Arévalo, Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Translational research Endocrine OncologyPancreatic CancerPathologyPancreatic Neuroendocrine TumorsMedicine	2022	21

Page 1